Remote SpringWorks Therapeutics Jobs
Upgrade to Premium for unlimited access to the largest remote job platform
- 100,000+ Global Remote Companies
- AI Deep Matching: Find jobs where you're a top 5 candidate
- Priority Access to Recruiters as a Certified Premium Talent
0 jobs found
0 jobs found
Sort by:
Relevance
Director, Regulatory Affairs for Advertising Promotion (AdPromo)
Director, Regulatory Affairs for Advertising Promotion (AdPromo)
30+ days ago
SpringWorks Therapeutics
72% flex
Matchscore
- Full time
- 167 - 220K
- Remote: United States
Senior Medical Science Liaison – Northeast RegionSenior Medical Science Liaison – Northeast Region
30+ days ago
SpringWorks Therapeutics
72% flex
Matchscore
- Full time
- 167 - 220K
- Remote: United States
Director, Clinical PharmacologyDirector, Clinical Pharmacology
30+ days ago
SpringWorks Therapeutics
72% flex
Matchscore
- Full time
- 184 - 240K
- Remote: United States
Regulatory Affairs Senior DirectorRegulatory Affairs Senior Director
23 days ago
SpringWorks Therapeutics
72% flex
Matchscore
- Full time
- 203 - 266K
- Remote: United States
Development Program Lead Senior DirectorDevelopment Program Lead Senior Director
30+ days ago
SpringWorks Therapeutics
72% flex
Matchscore
- Full time
- 223 - 293K
- Remote: United States
Not Seeing The Job You're Looking For?Not Seeing The Job You're Looking For?
30+ days ago
SpringWorks Therapeutics
72% flex
Matchscore
- Full time
- Remote: Réunion
New!
Do you want to see hybrid jobs?
More job openings are available if you are open to hybrid remote job positions.
Include hybrid jobs
Are you looking for a Remote SpringWorks Therapeutics Jobs?
Discover more about SpringWorks Therapeutics ?
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients living with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology pipeline spanning solid tumors and hematological cancers, including two potentially registrational clinical trials in rare tumor types as well as several programs addressing highly prevalent, genetically defined cancers.
